Skip to main content

Table 5 Rates of medication coverage for patients with diabetes, for the first quarter of each year, 2010 to 2016, administrative cohort

From: Impact of the diabetes Canada guideline dissemination strategy on dispensed vascular protective medications for older patients in Ontario, Canada: a linked EMR and administrative data study

Drug2010Q12011Q12012Q12013Q12014Q12015Q12016Q1
STATIN60.91%62.62%62.83%63.76%63.83%64.18%64.48%
ACEi or ARB61.94%61.80%60.87%60.72%60.30%59.72%59.16%
ANTIPLATELETS*10.23%9.97%9.40%8.79%8.14%7.48%6.91%
PPI22.92%23.91%24.57%25.56%26.14%26.72%27.34%
  1. *patients with a history of myocardial infarct were excluded
  2. ACEi: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blockers; PPI: proton pump inhibitor